ROBERT HERSHBERG
CIK 1274139 · President and CEO · last filed 2026-07-09
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.87M
Companies
7
Total Filings
71
Lifetime Open-Market Net
-$4.49M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| ATAI | Director | 100,000 | $7.25 | $725.0K | -$496.0K | 3 | 2026-07-09 |
| RXRX | Director | 162,156 | $3.29 | $533.5K | $0 | 10 | 2026-06-22 |
| ADPT | Director | 62,347 | $25.45 | $1.59M | -$2.67M | 22 | 2026-03-06 |
| HilleVax, Inc. (HLVX) Delisted | President and CEO | 0 | $2.09 | $0 | -$221.8K | 4 | 2025-09-17 |
| FATE | Director | 10,659 | $2.76 | $29.4K | -$15.3K | 5 | 2023-06-07 |
| ARS Pharmaceuticals, Inc. (SBTX) Delisted | Director | — | $5.87 | — | $0 | 3 | 2022-06-13 |
| NanoString Technologies Inc (NSTG) Delisted | Director | 10,716 | $0.11 | $1.1K | -$1.09M | 20 | 2022-04-18 |
Recent Filings · Page 4 of 8
71 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-10-05 | RXRX | Grant (A) | +572 | $0 | EDGAR |
| 2021-09-21 | ARS Pharmaceuticals, Inc. (SBTX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-07-06 | RXRX | Grant (A) | +347 | $0 | EDGAR |
| 2021-06-17 | NanoString Technologies Inc (NSTG) Delisted | Mixed | +5,520 | $0 | EDGAR |
| 2021-06-04 | FATE | Grant (A) | +2,681 | $0 | EDGAR |
| 2021-04-22 | RXRX | Conv (C) | — | $0 | EDGAR |
| 2021-04-19 | NanoString Technologies Inc (NSTG) Delisted | Mixed | — | -$8.5K | EDGAR |
| 2021-04-19 | RXRX | Grant (A) | +6,250 | $0 | EDGAR |
| 2021-03-17 | NanoString Technologies Inc (NSTG) Delisted | Mixed | — | -$83.6K | EDGAR |
| 2021-03-10 | ADPT | Mixed | — | -$88.2K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.